Covid-19 Update on WIPO's UDRP and ccTLD Case Operations

May 20, 2020

(Original date of publication: March 20, 2020)

In a communication of March 20, 2020, WIPO confirmed the deployment of its business continuity program in the face of the COVID-19 outbreak.

As part of its overall response to this global crisis, WIPO remains committed to providing its full domain name dispute resolution services.

Indeed, significant numbers of cases continue to be filed with WIPO, notably in the biotech/pharma, Internet/IT, banking/finance, and events-related categories.

(This includes cases concerning COVID-19 related domain names, such as:  <coronagileadsciences.com> (WIPO Case No. D2020-0776), <dettolhandsanitizer.com>,  <facebookcovid19.com>, <gileadcopay.co>, <hmrc‑refund‑covid‑19.com>, <tokyo2021.cn>, <tokyo2021.org>, <sanofivaccine.com> and <wwwlillycovid19testing.com>.)

As the situation continues to evolve and impact individuals and businesses worldwide, parties are kindly requested to understand that a degree of flexibility and discretion may be appropriate or necessary in individual case scenarios.

As before, you may submit:

We thank all parties and UDRP stakeholders. Any material developments will be posted.

With our best wishes,

WIPO Arbitration and Mediation Center